Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease.

Coimbra S, Brandão Proença J, Santos-Silva A, Neuparth MJ.

Biomed Res Int. 2014;2014:701915. doi: 10.1155/2014/701915. Epub 2014 Jul 2.

2.

Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes.

Andersson DP, Laurencikiene J, Acosta JR, Rydén M, Arner P.

J Clin Endocrinol Metab. 2016 Oct;101(10):3765-3771. Epub 2016 Aug 8.

3.

Circulating Chemerin Is Associated With Carotid Plaque Instability, Whereas Resistin Is Related to Cerebrovascular Symptomatology.

Gasbarrino K, Mantzoros C, Gorgui J, Veinot JP, Lai C, Daskalopoulou SS.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1670-8. doi: 10.1161/ATVBAHA.115.306741. Epub 2016 Jun 16.

4.

Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?

Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.

Gynecol Endocrinol. 2016;32(1):38-41. doi: 10.3109/09513590.2015.1075501. Epub 2015 Aug 18.

PMID:
26291816
5.

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.

Kort DH, Kostolias A, Sullivan C, Lobo RA.

Gynecol Endocrinol. 2015 Feb;31(2):152-5. doi: 10.3109/09513590.2014.968547. Epub 2014 Oct 8.

PMID:
25295622
6.

Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.

Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H, AlSaif S.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1296-1302.

7.

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.

Tönjes A, Fasshauer M, Kratzsch J, Stumvoll M, Blüher M.

PLoS One. 2010 Nov 9;5(11):e13911. doi: 10.1371/journal.pone.0013911.

8.

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.

Alfadda AA, Sallam RM, Chishti MA, Moustafa AS, Fatma S, Alomaim WS, Al-Naami MY, Bassas AF, Chrousos GP, Jo H.

Mol Cells. 2012 Jun;33(6):591-6. doi: 10.1007/s10059-012-0012-7. Epub 2012 Apr 27.

9.

[Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].

Wang LY, Wei L, Yu HY, Zhang Y, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 3;89(4):235-8. Chinese.

PMID:
19552838
10.

Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents.

Reinehr T, Woelfle J, Wiegand S, Karges B, Meissner T, Nagl K, Holl RW.

Pediatr Diabetes. 2016 Jun;17(4):281-8. doi: 10.1111/pedi.12276. Epub 2015 Apr 16.

PMID:
25882767
11.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
12.

Serum Leptin and Adiponectin Concentration in Type 2 Diabetes Patients in the Short and Long Term Following Biliopancreatic Diversion.

Adami GF, Gradaschi R, Andraghetti G, Scopinaro N, Cordera R.

Obes Surg. 2016 Oct;26(10):2442-8. doi: 10.1007/s11695-016-2126-z.

PMID:
26989058
13.

Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?

Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, Yang X.

Diabetes Metab Res Rev. 2010 Feb;26(2):109-14. doi: 10.1002/dmrr.1060.

PMID:
20058257
14.

Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.

Yu S, Zhang Y, Li MZ, Xu H, Wang Q, Song J, Lin P, Zhang L, Liu Q, Huang QX, Wang K, Hou WK.

Chin Med J (Engl). 2012 Oct;125(19):3440-4.

PMID:
23044303
15.

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.

Int J Obes (Lond). 2007 Feb;31(2):213-20. Epub 2006 Jun 6.

PMID:
16755284
16.

Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism.

Takahashi M, Inomata S, Okimura Y, Iguchi G, Fukuoka H, Miyake K, Koga D, Akamatsu S, Kasuga M, Takahashi Y.

Endocr J. 2013;60(1):37-44. Epub 2012 Oct 13.

17.
18.

Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines.

Reinehr T, Karges B, Meissner T, Wiegand S, Stoffel-Wagner B, Holl RW, Woelfle J.

J Pediatr. 2016 Jun;173:131-5. doi: 10.1016/j.jpeds.2016.02.055. Epub 2016 Mar 17.

PMID:
26996723
19.

Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes.

Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS.

J Korean Med Sci. 2016 Jun;31(6):924-31. doi: 10.3346/jkms.2016.31.6.924. Epub 2016 Apr 26.

20.

The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.

Ozenoglu A, Balci H, Ugurlu S, Caglar E, Uzun H, Sarkis C, Gunay C, E EE.

Clinics (Sao Paulo). 2008 Oct;63(5):651-60.

Supplemental Content

Support Center